首页> 外国专利> LOW-CONTENT FLURBIPROFEN AXETIL PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF

LOW-CONTENT FLURBIPROFEN AXETIL PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF

机译:低含量的Flbiprofen Axetil药物组合物及其应用

摘要

Provided is an application of flurbiprofen axetil in preparing a pharmaceutical composition for relieving fever in patients by an intravenous administration route. The pharmaceutical composition comprises: 10-40 mg of flurbiprofen axetil. Furthermore, the content of flurbiprofen axetil is 10-35 mg, 15-35 mg, or 15-30 mg, and is preferably 15 mg or 30 mg. The provided low-content flurbiprofen axetil pharmaceutical composition can be securely and effectively used for relieving fever in adult patients. Moreover, surprisingly, the low-content flurbiprofen axetil pharmaceutical composition has the same fever relieving effect and duration as a high-content flurbiprofen axetil pharmaceutical composition, and has a less adverse reaction. Compared with the ibuprofen injection, the single administration of the provided low-dose flurbiprofen axetil can maintain the fever relieving time above 6-10 hours, which significantly reduces the administration frequency and improves the patient compliance.
机译:提供了Flubrofen Axetil在制备用于通过静脉内给药途径缓解发烧的药物组合物的应用。药物组合物包含:10-40mg Flbiprofen Axetil。此外,Flbiprofen Axetil的含量为10-35mg,15-35mg或15-30mg,优选为15mg或30mg。提供的低含量氟芬施用药物组合物可以牢固,有效地用于缓解成人患者的发烧。此外,令人惊讶的是,低含量的Flbiprofen Axetil药物组合物具有相同的发烧缓解效应和持续时间,作为高含量的佛罗夫芬·药物药物组合物,具有较小的不良反应。与布洛芬注射液相比,所提供的低剂量氟氯芬Xetil的单一施用可以将发热缓解时间保持在6-10小时以上,这显着降低了给药频率并提高了患者的顺应性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号